![]() |
Name |
4,6-Dihydroxy-5-methoxy-7-methyl-1,3-dihydroisobenzofuran
|
Molecular Formula | C10H12O4 | |
IUPAC Name* |
5-methoxy-7-methyl-1,3-dihydro-2-benzofuran-4,6-diol
|
|
SMILES |
CC1=C2COCC2=C(C(=C1O)OC)O
|
|
InChI |
InChI=1S/C10H12O4/c1-5-6-3-14-4-7(6)9(12)10(13-2)8(5)11/h11-12H,3-4H2,1-2H3
|
|
InChIKey |
CCIMZPYSIJENDN-UHFFFAOYSA-N
|
|
Synonyms |
4,6-dihydroxy-5-methoxy-7-methyl-1,3-dihydroisobenzofuran
|
|
CAS | NA | |
PubChem CID | 123784052 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 196.2 | ALogp: | 0.8 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 58.9 | Aromatic Rings: | 2 |
Heavy Atoms: | 14 | QED Weighted: | 0.72 |
Caco-2 Permeability: | -4.784 | MDCK Permeability: | 0.00001360 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.013 |
Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.011 |
30% Bioavailability (F30%): | 0.071 |
Blood-Brain-Barrier Penetration (BBB): | 0.119 | Plasma Protein Binding (PPB): | 78.98% |
Volume Distribution (VD): | 0.57 | Fu: | 8.48% |
CYP1A2-inhibitor: | 0.357 | CYP1A2-substrate: | 0.948 |
CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.764 |
CYP2C9-inhibitor: | 0.019 | CYP2C9-substrate: | 0.323 |
CYP2D6-inhibitor: | 0.025 | CYP2D6-substrate: | 0.331 |
CYP3A4-inhibitor: | 0.028 | CYP3A4-substrate: | 0.2 |
Clearance (CL): | 8.006 | Half-life (T1/2): | 0.936 |
hERG Blockers: | 0.12 | Human Hepatotoxicity (H-HT): | 0.475 |
Drug-inuced Liver Injury (DILI): | 0.099 | AMES Toxicity: | 0.509 |
Rat Oral Acute Toxicity: | 0.49 | Maximum Recommended Daily Dose: | 0.041 |
Skin Sensitization: | 0.909 | Carcinogencity: | 0.224 |
Eye Corrosion: | 0.009 | Eye Irritation: | 0.904 |
Respiratory Toxicity: | 0.183 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004505 | ![]() |
1.000 | D04FBR | ![]() |
0.238 | ||
ENC002071 | ![]() |
0.659 | D06GCK | ![]() |
0.216 | ||
ENC005415 | ![]() |
0.659 | D07MEH | ![]() |
0.210 | ||
ENC004922 | ![]() |
0.590 | D09EBS | ![]() |
0.203 | ||
ENC004362 | ![]() |
0.560 | D0WY9N | ![]() |
0.200 | ||
ENC002722 | ![]() |
0.560 | D0G4KG | ![]() |
0.197 | ||
ENC005913 | ![]() |
0.560 | D07MGA | ![]() |
0.193 | ||
ENC004504 | ![]() |
0.500 | D0J4IX | ![]() |
0.190 | ||
ENC004923 | ![]() |
0.446 | D08SKH | ![]() |
0.183 | ||
ENC005914 | ![]() |
0.421 | D06XZW | ![]() |
0.181 |